Şunu aradınız:: emoglobinopatiji (Maltaca - İngilizce)

emoglobinopatiji bħal talessimja jew sickle cell anaemia
haemoglobinopathies such as thalassaemia or sickle cell anaemia

• emoglobinopatiji bħal talessimja jew sickle cell anaemia od
• hyperparathyroidism/ osteitis fibrosa cystica • aluminium intoxication m

emoglobinopatiji (eż., talassemija, anemija biċ-ċelluli forma ta’ minġel).
haemoglobinopathies (e.g., thalassemia, sickle-cell anaemia).

- mhux magħruf jekk mircera għandux effett differenti f’ pazjenti b’ emoglobinopatiji (mard
- it is not known if mircera has a different effect in patients with haemoglobinopathies

fil- maġġoranza tal- pazjenti b’ disturbi fiċ- ċiklu ta ’ l- urea jew b’ emoglobinopatiji li kienu qed jirċievu diversi dożi ta ’ phenylbutyrate (300 - 650 mg/ kg/ kuljum sa 20 g/ kuljum) ma seta ’ jkun osservat l- ebda livell ta ’ phenylacetate fil- plażma wara lejl li fih il- pazjent ma ħa xejn.
in the majority of patients with urea cycle disorders or haemoglobinopathies receiving various doses of phenylbutyrate (300 - 650 mg/ kg/ day up to 20 g/ day) no plasma level of phenylacetate could be detected after overnight fasting.